Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Forma Therapeutics logo — Dedicated to transforming the lives of patients with rare he...

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.

Founded 2007 United States Watertown, United States 159 employees Series D Total: $142.50M Biotechnology, Health Care +1

General Information

Company Name Forma Therapeutics
Founded Year 2007
Location United States Watertown, United States
Employees 159
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Forma Therapeutics. To contact Forma Therapeutics, visit formatherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Forma Therapeutics compare?

A PDF of Forma Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Forma Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with rare hematologic diseases and cancers. With a focus on research, development, and commercialization of novel therapeutics, the company integrates deep biology insight, chemistry expertise, and clinical development capabilities to create drug candidates with differentiated mechanisms of action for indications with high unmet need. Founded in 2007 and based in the United States, Forma Therapeutics has attracted significant investment, with their last Series D investment amounting to $100.00M from notable investors including RA Capital Management, Wellington Management, Janus Handerson, Samsara BioCapital, Cormorant Asset Management, and Baker Brothers Advisors LLC in December 19, 2019. The company's mission reflects a commitment to creating futures for patients, their families, and employees. For those interested in contributing to their mission, career opportunities and benefits packages can be found on their website.

Business keywords: biopharmaceutical, clinical-stage, rare diseases, cancer research, drug development, oncology, genomic medicine, biological insight, chemistry expertise, patient benefit, innovative drug discovery, cancer therapy, oncology drugs

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $100.00M 6
RA Capital Management Wellington Management Janus Handerson
RA Capital Management, Wellington Management +4
19 Dec 2019
Series C $10.00M 2
Novartis Venture Fund Lilly Ventures
Novartis Venture Fund, Lilly Ventures
07 Sep 2012
Series B $3.00M 2
EDBI Novartis Venture Fund
EDBI, Novartis Venture Fund
17 Dec 2009
Series B $25.50M -
01 Dec 2009
Series A $4.00M -
14 Apr 2008

Forma Therapeutics Alternatives & Competitors

View All Alternatives
Forma Therapeutics vs
AN2 Therapeutics
AN2 Therapeutics United States

Developing therapies for rare, chronic, and serious infectious diseases

Grant
35 employees
Biotechnology, Health Care
Compare Forma Therapeutics vs AN2 Therapeutics
Forma Therapeutics vs
Lumos Pharma
Lumos Pharma United States

Transforming Lives with Rare Focus

Series B
47 employees
Biopharma, Biotechnology
Forma Therapeutics vs
Pannex Therapeutics Inc.
Pannex Therapeutics Inc. United States

We are the Pannexin people.

Seed
4 employees
Biotechnology, Pharmaceutical
Also compare with: Forma Therapeutics vs Santhera Pharmaceuticals Santhera Pharmaceuticals View all alternatives

FAQ About Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.
Forma Therapeutics was founded in 2007.
Forma Therapeutics is headquartered in Watertown, United States.
Forma Therapeutics operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical, clinical-stage, rare diseases and cancer research.
Forma Therapeutics has approximately 159 employees.
Forma Therapeutics has completed 5 funding rounds, raising a total of $142.50M. The latest funding stage is Series D.
Top alternatives and competitors to Forma Therapeutics include AN2 Therapeutics, Lumos Pharma, Pannex Therapeutics Inc., Ayala Pharmaceuticals , Blueprint Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Forma Therapeutics and AN2 Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Forma Therapeutics, https://bouncewatch.com/company/forma-therapeutics, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes